Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01):
a pilot study
To access this article, please choose from the options below
PII: S0145-2126(00)00036-9
© 2000 Elsevier Science Ltd. All rights reserved.
